Fapon Biopharma to Present Next-Generation CD3/ TCR VHH TCE Platform at 19th Annual European Life Sciences CEO Forum

Fapon Biopharma Switzerland

(USA, Europe and other regions) or [e-mail] (Asia-Pacific)

About Fapon Biopharma:

Fapon Biopharma specializes in discovering and developing biologics for cancer treatment, autoimmune diseases and other diseases where there are unmet medical needs. Leveraging cutting-edge technologies, we have built advanced drug discovery platforms, including an antibody discovery platform based on the globally leading mammalian cell display technology, a platform for generating IL-10M fusion proteins, a TCE platform based on cross-species CD3-VHH of human and monkey. With a differentiated pipeline of leading drug candidates, we have established capabilities that cover the entire drug development process from drug discovery, preclinical research, Chemistry, Manufacturing and Controls (CMC) to early clinical development. Committed to innovation, we strive to deliver safer, more efficacious, affordable, and accessible biologics for everyone.

Logo - https://mma.prnewswire.com/media/2472549/Fapon_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/fapon-biopharma-to-present-next-generation-cd3tcr-vhh-tce-platform-at-19th-annual-european-life-sciences-ceo-forum-302703506.html